Mariner LLC Purchases Shares of 923,786 Tempus AI, Inc. (NASDAQ:TEM)

Mariner LLC acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 923,786 shares of the company's stock, valued at approximately $31,187,000. Mariner LLC owned 0.59% of Tempus AI as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Victory Capital Management Inc. bought a new position in Tempus AI during the fourth quarter worth $216,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Tempus AI in the 4th quarter valued at $1,091,000. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Tempus AI in the fourth quarter valued at approximately $178,000. abrdn plc bought a new stake in shares of Tempus AI during the fourth quarter worth $2,784,000. Finally, Dakota Wealth Management increased its position in Tempus AI by 189.7% in the 4th quarter. Dakota Wealth Management now owns 60,668 shares of the company's stock valued at $2,048,000 after acquiring an additional 39,724 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insider Transactions at Tempus AI

In other news, Director Nadja West sold 809 shares of the firm's stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $51.11, for a total value of $41,347.99. Following the transaction, the director now owns 37,705 shares in the company, valued at $1,927,102.55. This trade represents a 2.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Eric P. Lefkofsky sold 476,209 shares of Tempus AI stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the transaction, the chief executive officer now directly owns 6,502,643 shares in the company, valued at $324,091,727.12. This represents a 6.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,146,249 shares of company stock valued at $301,185,058 in the last quarter.

Tempus AI Trading Down 1.1 %

NASDAQ TEM traded down $0.44 on Friday, hitting $40.42. 4,560,129 shares of the company's stock were exchanged, compared to its average volume of 5,515,313. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The stock has a 50-day moving average of $54.10 and a 200-day moving average of $50.60. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Analyst Ratings Changes

TEM has been the topic of several recent research reports. Piper Sandler reduced their target price on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Bank of America lifted their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research note on Monday, March 3rd. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Thursday, April 10th. JPMorgan Chase & Co. cut shares of Tempus AI from an "overweight" rating to a "neutral" rating and lifted their price target for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Finally, Morgan Stanley upped their price objective on shares of Tempus AI from $50.00 to $60.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $61.18.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.